Hydroxylated decahydroquinolines as ligands for the vesicular acetylcholine transporter: Synthesis and biological evaluation

Journal of Medicinal Chemistry

Volumn 42, Issue 15, 1999, Pages 2862-2869

  Efange, Simon M N ^a,d   Khare, Anil B ^a   Mach, Robert H ^b   Parsons, Stanley M ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; DECAHYDROQUINOLINE DERIVATIVE; SIGMA OPIATE RECEPTOR; VESAMICOL; VESAMICOL DERIVATIVE; VESICULAR ACETYLCHOLINE TRANSPORTER;

ARTICLE; BINDING AFFINITY; CHEMICAL ANALYSIS; CHEMICAL BINDING; CHEMICAL STRUCTURE; HYDROXYLATION; STEREOCHEMISTRY; SYNTHESIS;

ACETYLCHOLINE; ANIMALS; CARRIER PROTEINS; ELECTRIC ORGAN; GUINEA PIGS; LIGANDS; MEMBRANE TRANSPORT PROTEINS; QUINOLINES; RADIOLIGAND ASSAY; RECEPTORS, SIGMA; STRUCTURE-ACTIVITY RELATIONSHIP; SYNAPTIC VESICLES; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS; VESICULAR TRANSPORT PROTEINS;

EID: 0033614921     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm980560x     Document Type: Article

References (40)

1. Alphonso, A.; Grundahl, K.; Duerr, J. S.; Han, H.-P.; Rand, J. B. The Caenorhabditis elegans unc-17 gene: a putative vesicular acetylcholine transporter. Science 1993, 261, 617-619.
2. Varoqui, H.; Diebler, M.-F.; Meunier, F.-M.; Rand, J. B.; Usdin, T. B.; Bonner, T. I.; Eiden, L. E.; Erickson, J. D. Cloning and expression of the vesamicol binding protein from the marine ray Torpedo. Homology with the putative vesicular acetylcholine transporter UNC-17 from Caenorhabditis elegans. FEBS Lett. 1994, 342, 97-102.
3. Kitamoto, T.; Wang, W.; Salvaterra, P. M. Structure and organization of the Drosophila cholinergic locus. J. Biol. Chem. 1998, 273, 2706-2713.
4. Nacif, J. M.; Misawa, H.; Dedman, J. R. Molecular characterization of the mouse vesicular acetylcholine transporter gene. Neuroreport 1997, 8, 3467-3473.
5. Roghani, A.; Feldman, J.; Kohan, S. A.; Shirzadi, A.; Gundersen, C. B.; Brecha, N.; Edwards, R. H. Molecular cloning of a putative vesicular transporter for acetylcholine. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 10620-10624.
6. Erickson, J. D.; Varoqui, H.; Schafer, M. K.-H., Modi, W.; Diebler, M.-F.; Weihe, E.; Rand, J.; Eiden, L. E.; Bonner, T. I.; Usdin, T. B. Functional identification of a vesicular acetylcholine transporter and its expression from a "cholinergic" gene locus. J. Biol. Chem. 1994, 269, 21929-21932.
7. Usdin, T. B.; Eiden, L. E.; Bonner, T. I.; Erickson, J. D. Molecular biology of the vesicular acetylcholine transporter. Trends Neurosci. 1995, 18, 218-224.
8. Bejanin, S.; Cervini, R.; Mallet, J.; Berrard, S. A unique gene organization for two cholinergic markers, choline acetyltransferase and a putative vesicular transporter of acetylcholine. J. Biol. Chem. 1994, 269, 21944-21947.
9. Alfonso, A.; Grundahl, K.; McManus, J. R.; Asbury, J. M.; Rand, J. B. Alternative splicing leads to two cholinergic proteins in Caenorhabditis elegans. J. Mol. Biol. 1994, 241, 627-630.
10. Schafer, M. K.-H.; Weihe, E.; Varoqui, H.; Eiden, L. E.; Erickson, J. D. Distribution of the vesicular acetylcholine transporter (VAChT) in the central and peripheral nervous systems of the rat. J. Mol. Neurosci. 1994, 5, 1-26.
11. Schafer, M. K.-H.; Weihe, E.; Erickson, J. D.; Eiden, L. E. Human and monkey cholinergic neurons visualized in paraffin-embedded tissues by immunoreactivity for VAChT, the vesicular acetylcholine transporter. J. Mol. Neurosci. 1995, 6, 225-235.
12. Weihe, E.; Tao-Cheng, J. H.; Schafer, M. K. H.; Erickson, J. D.; Eiden, L. E. Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles. Proc. Natl Acad. Sci. U.S.A. 1996, 93, 3547-3552.
13. Ichikawa, T.; Ajiki, K.; Matsuura, J.; Misawa, H. Localization of two cholinergic markers, choline acetyltransferase and vesicular acetylcholine transporter in the central nervous system of the rat: in situ hybridization histochemistry and immunohistochemistry. J. Chem. Neuroanat. 1997, 13, 23-39.
14. Gilmor, M. L.; Nash, N. R.; Roghani, A.; Edwards, R. H.; Yi, H.; Hersch, S. M.; Levey, A. I. Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles. J. Neurosci. 1996, 16, 2179-2190.
15. Parsons, S. M.; Prior, C.; Marshall, I. G. Acetylcholine transport, storage and release. Int. Rev. Neurobiol. 1993, 35, 279-390.
16. Prior, C.; Marshall, I. G.; Parsons, S. M. The pharmacology of vesamicol: an inhibitor of the vesicular acetylcholine transporter. Gen. Pharmacol. 1992, 23, 1017-1022.
17. Parsons, S. M.; Prior, C.; Marshall, I. G. Acetylcholine transport, storage and release. Int. Rev. Neurobiol. 1993, 35, 279-390.
18. Brittain, R. T.; Levy, G. P.; Tyers, M. B. The neuromuscular blocking action of 2-(4-phenylpiperidino)cyclohexanol (AH 5183). Eur. J. Pharmacol. 1969, 8, 93-99.
19. Marshall, I. G. Studies on the blocking action of 2-(4-phenylpiperidino)cyclohexanol (AH 5183). Br. J. Pharmacol. 1970, 38, 503-516.
20. Wannan, G.; Prior, C.; Marshall I. G. α-Adrenoceptor blocking properties of vesamicol. Eur. J. Pharmacol. 1991, 201, 29-34.
21. Efange, S. M. N.; Mach, R. H.; Smith, C. R.; Khare, A. B.; Foulon, C.; Akella, S. K.; Childers, S. R.; Parsons, S. M. Vesamicol analogues as sigma ligands: Molecular determinants of selectivity at the vesamicol receptor. Biochem. Pharmacol. 1994, 49, 791-797.
22. Rogers, G. A.; Parsons, S. M.; Anderson, D. C.; Nilsson, L. M.; Bahr, B. A.; Kornreich, W. D.; Kaufman, R.; Jacobs, R. S.; Kirtman, B. Synthesis, in vitro acetylcholine-storage-blocking activities, and biological properties of derivatives and analogues of trans-2-(4-phenylpiperidino)cyclohexanol (vesamicol). J. Med. Chem. 1989, 32, 1217-1230.
23. Efange, S. M. N.; Michelson, R. H.; Dutta, A. K.; Parsons, S. M. Acyclic analogues of 2-(4-phenylpiperidino) cyclohexanol (vesamicol): Conformationally mobile inhibitors of vesicular acetylcholine transport. J. Med. Chem. 1991, 34, 2638-2643.
24. Efange, S. M. N.; Khare, A. B.; Parsons, S. M.; Bau, R.; Metzenthin, T. Nonsymmetrical bipiperidyls as inhibitors of vesicular acetylcholine storage. J. Med. Chem. 1993, 36, 985-989.
25. Efange, S. M. N.; Khare, A. B.; Foulon, C.; Akella, S. K.; Parsons, S. M. Spirovesamicols: Conformationally restricted analogues of 2-(4-phenylpiperidino)-cyclohexanol (vesamicol, AH5183) as potential modulators of presynaptic cholinergic function. J. Med Chem. 1994, 37, 2574-2582.
26. Jung, Y.-W.; Frey, K. A.; Mulholland, G. K.; del Rosario, R.; Sherman, P. S.; Raffel, D. M.; van Dort, M. E.; Kuhl, D. E.; Gildersleeve, D. L.; Wieland, D. M. Vesamicol receptor mapping of brain cholinergic neurons with radioiodine-labeled positional isomers of benzovesamicol. J. Med. Chem. 1996, 39, 3331-3342.
27. Efange, S. M.; Kamath, A. P.; Khare, A. B.; Kung, M. P.; Mach, R. H.; Parsons, S. M. N-Hydroxyalkyl Derivatives of 3-β-Phenyltropane and 1-methylspiro[1H-indoline-3,4′-piperidine]: Vesamicol Analogues With Affinity for Monoamine Transporters and Receptors. J. Med. Chem. 1997, 40, 3905-3914.
28. 125I]MIBT): potential radiotracer for mapping central cholinergic innervation. J. Med. Chem. 1993, 36, 1754-1760.
29. 18F]FBT): molecular decomposition-reconstitution approach to vesamicol receptor radioligands. Appl. Radiat. Isot. 1994, 45, 465-472.
30. Coffeen, P. R.; Efange, S. M. N.; Haidet, G. C.; McNite, S.; Langason, R. B.; Khare, A. B.; Pennington, J.; Lune, K. G. Measurement of functional cholinergic innervation in rat heart with a novel vesamicol receptor ligand. Nucl. Med. Biol. 1996, 23, 923-926.
31. 2 Receptor Blockade in the 6-Hydroxydopamine (6-OHDA)-lesioned rat: possible implications for Parkinson's Disease. Life Sci. 1996, 58 (16), 1367-1375.
32. Efange, S. M. N.; Langason, R. B.; Khare, A. B. Age-Related Diminution of Dopamine Antagonist-Stimulated Vesamicol Receptor Binding. J. Nucl. Med. 1996, 37, 1192-1197.
33. 18F]4-fluorobenzyltrozamicol. In vitro binding studies and positron emission tomography studies in nonhuman primates. Synapse 1997, 25, 368-380.
34. Efange, S. M. N.; Garland, E.; Staley, J. K.; Khare, A. B.; Mash, D. C. Vesicular Acetylcholine Transporter (VAChT) Density and Alzheimer's Disease. Neurobiol. Aging 1997, 18, 407-413.
35. 125I]MIBT in primate Brain. Eur. J. Pharmacol. 1997, 338, 159-169.
36. Rogers, G. A.; Kornreich, W. D.; Hand, K.; Parsons, S. M. Kinetic and equilibrium characterization of vesamicol receptor-ligand complexes with picomolar dissociation constants. Mol. Pharmacol. 1993, 44, 633-641.
37. Lewin, A. H.; Sun, G.; Fudala, L.; Navarro, H.; Zhou, L.-M.; Popik, P.; Faynsteyn, A.; Skolnick, P. Molecular features associated with polyamine modulation of NMDA receptors. J. Med. Chem. 1998, 41, 988-995.
38. House, H. O.; Rasmusson, G. H. Perhydroindanone derivatives. II. Stability relationships. J. Org. Chem. 1963. Maurer, B.; Hauser, A. Helv. Chim. Acta 1982, 65, 462.
39. House, H. O.; Rasmusson, G. H. Perhydroindanone derivatives. II. Stability relationships. J. Org. Chem. 1963. Maurer, B.; Hauser, A. Helv. Chim. Acta 1982, 65, 462.
40. Ibuka, T.; Masaki, N.; Saji, I.; Tanaka, K.; Inubushi, Y. Synthesis of dl-pumiliotoxin C hydrochloride and its crystal structure. Chem. Pharm. Bull. 1975, 23, 2779-2790.